Immunic, Inc. short interest in 2020
In 2020, Immunic, Inc.'s disclosed short interest ran from 0.53% of shares outstanding on 15 Jan 2020 to 4.50% on 31 Dec 2020, a change of +3.97 percentage points. The year's high was 7.10% on 30 Sep 2020 and its low 0.36% on 31 Jan 2020, averaging 2.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.88 days on 15 Dec 2020. Full history: Immunic, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 0.53% (15 Jan 2020)
- End of year
- 4.50% (31 Dec 2020)
- Change
- +3.97 pp
- High
- 7.10% (30 Sep 2020)
- Low
- 0.36% (31 Jan 2020)
- Average
- 2.18%
- Highest days to cover
- 4.88 (15 Dec 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 0.53% | 3.89 | |
| 31 Jan 2020 | 0.36% | 1.70 | |
| 14 Feb 2020 | 0.37% | 2.55 | |
| 28 Feb 2020 | 0.40% | 3.39 | |
| 13 Mar 2020 | 0.39% | 4.59 | |
| 31 Mar 2020 | 0.49% | 1.10 | 10-K filed, results (8-K) |
| 15 Apr 2020 | 0.48% | 2.18 | |
| 30 Apr 2020 | 0.60% | 1.00 | |
| 15 May 2020 | 1.14% | 1.00 | 10-Q filed, results (8-K) |
| 29 May 2020 | 0.51% | 1.00 | |
| 15 Jun 2020 | 0.45% | 1.00 | |
| 30 Jun 2020 | 1.04% | 1.00 | |
| 15 Jul 2020 | 1.14% | 1.00 | |
| 31 Jul 2020 | 0.94% | 1.00 | |
| 14 Aug 2020 | 1.75% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 3.13% | 1.00 | |
| 15 Sep 2020 | 5.13% | 1.24 | |
| 30 Sep 2020 | 7.10% | 2.33 | |
| 15 Oct 2020 | 4.69% | 2.41 | |
| 30 Oct 2020 | 4.91% | 3.20 | |
| 13 Nov 2020 | 3.79% | 3.43 | results (8-K), 10-Q filed |
| 30 Nov 2020 | 5.06% | 2.96 | |
| 15 Dec 2020 | 3.34% | 4.88 | |
| 31 Dec 2020 | 4.50% | 3.64 |
See also: Immunic, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.